Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 33

Trial Status

Completed5

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT03926052Phase 3Completed
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment
Binge-Eating DisorderObesity
PrincipalinvestigatorStart date: 2019-08-07
NCT03924193Phase 3Completed
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment
Binge-Eating DisorderObesity
PrincipalinvestigatorStart date: 2019-03-25
NCT02259322Not ApplicableCompleted
Loss of Control Eating Following Weight Loss Surgery
Loss of Control Eating
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Yale University

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT03926052Phase 3PrincipalInvestigator

Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment

Binge-Eating DisorderObesity
Completed
NCT03946111Phase 2/3PrincipalInvestigator

Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders

Binge-Eating DisorderObesity
Completed
NCT03924193Phase 3PrincipalInvestigator

Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment

Binge-Eating DisorderObesity
Completed
NCT02259322Not ApplicablePrincipalInvestigator

Loss of Control Eating Following Weight Loss Surgery

Loss of Control Eating
Completed
NCT02317744Not ApplicablePrincipalInvestigator

Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo

Binge Eating Disorder
Completed

All 5 trials loaded